z-logo
open-access-imgOpen Access
Myeloperoxidase -463 G/A polymorphism is associated with lung cancer risk
Author(s) -
Shengqiang Zou,
Xin Pan,
Changsong Hua,
Min Wu,
Bin He,
Zhigang Chen
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.235341
Subject(s) - lung cancer , odds ratio , medicine , confidence interval , subgroup analysis , gastroenterology , myeloperoxidase , meta analysis , lung cancer susceptibility , oncology , genotype , single nucleotide polymorphism , biology , genetics , inflammation , gene
Several studies evaluated the association between myeloperoxidase (MPO) -463 G/A polymorphism and the risk of lung cancer. However, the results were not stable.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here